An optimized method for obtaining clinical-grade specific cell subpopulations from human umbilical cord-derived mesenchymal stem cells.

Based on the above, the authors tried to establish a general five-step operation procedure for acquiring high-quality clinical-grade MSC subpopulations based on specific markers, which cannot only improve their enrichment efficiency and the reliability of preclinical studies, but also provide valuable ological guidance for the rapid clinical transformation of specific MSC subpopulations.

Researchers relied on Countstar (model not specified) for cell-viability measurements in the study's cell samples during quality assessment in the 2022 Cell proliferation study.